Recent studies have shown a significant expression of TGF-β1 in patients with pulmonary fibrosis [55]; in this regard, our results showed that treatment with KYP-2047 significantly reduced TGF-β1 protein levels in the lung lesion. Here, TGFB1 is linked to pulmonary fibrosis.